Mirror mirror on the wall, who is going to be readmitted after all?

Aleksander Dokollari, Gianluca Torregrossa

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In the jungle of biomarkers that predicts long-term outcome, there are many discrepancies and there is more evidence from single-center retrospective studies rather than clinical trials. While some of these biomarkers such as high sensitivity troponin levels, creatine kinase (CK), and CK-MB have demonstrated a good pattern for patients’ follow-up, other biomarkers are still struggling to get validated and internationally renown due to the small number of patients included in the studies and their retrospective nature. In this context, Brown and colleagues must be congratulated as they have marked the pathway for future clinical trials.

Original languageEnglish
Pages (from-to)4224-4225
Number of pages2
JournalJournal of Cardiac Surgery
Volume36
Issue number11
DOIs
StatePublished - Nov 2021
Externally publishedYes

Keywords

  • NT proBNP
  • cytostatin C
  • long-term follow-up
  • risk score

Fingerprint

Dive into the research topics of 'Mirror mirror on the wall, who is going to be readmitted after all?'. Together they form a unique fingerprint.

Cite this